TPIV200
16-011
Phase 2 mab completed
Quick answer
TPIV200 for Ovarian Cancer is a Phase 2 program (mab) at Marker Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Marker Therapeutics
- Indication
- Ovarian Cancer
- Phase
- Phase 2
- Modality
- mab
- Status
- completed